Combat Medical Raises £2.6 Million Series A to Advance Treatment of BCG Unresponsive Bladder Cancer
Investment led by T&J Meyer Family Foundation, joined by Varia Ventures, NW Angel Fund and other non-institutional investors Financing advances Combat’s HIVEC®... Read more.
Level Access Supercharges Partner Program to Accelerate Digital Accessibility
IBM, Slalom, Merkle, and more will harness the power of Level Access’s platform to deliver inclusive customer experiences STAFFORD, Va.–(BUSINESS WIRE)–Level... Read more.
Egon Zehnder and IMD Join Forces to Boost Board Performance and Leadership Growth
ZURICH & LAUSANNE, Switzerland–(BUSINESS WIRE)–#Acquisition–Egon Zehnder, the world’s premier leadership advisory and executive search firm,... Read more.
EcoOnline Launches Mega Trends Report as 2025 Momentum Reflects the Shift from Compliance to Connected Risk
Eighteen months of EcoOnline primary research highlights seven shifts reshaping safety and sustainability, mirrored in the company’s 2025 customer adoption, product... Read more.
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
Former Rune Labs and Glooko executive to lead MindMaze’s next phase of growth, focusing on U.S. market expansion and the delivery of scalable, AI-driven neurorestorative... Read more.
Almirall Inaugurates Offices in China to Advance Innovation in Medical Dermatology Through Partnerships
Almirall Institutional Event Shanghai The biopharmaceutical company’s presence in Shanghai, China is dedicated to life science innovation and business development... Read more.
Arista Announces XPO High Density Liquid Cooled Pluggable Optics
Multi-source Agreement for 64-channel XPO module delivering 12.8Tbps capacity SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE: ANET) today... Read more.
BW LPG Limited – Ex Dividend US$0.57 on the Oslo Stock Exchange Today
SINGAPORE–(BUSINESS WIRE)–With reference to the press release dated 3 March 2026 by BW LPG Limited (“BW LPG” or the “Company”, OSE ticker code:... Read more.
Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced... Read more.
Redslim expands into Asia-Pacific to support global brands with data and AI infrastructure
ZUG, Switzerland–(BUSINESS WIRE)–#AI–Redslim, a specialist in end-to-end data management solutions and an Astorg portfolio company, today announced... Read more.